Prime Medicine, Inc. (PRME)
USD 2.64
(-9.28%)
USD 2.64
(-9.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -165.41 Million | -131.82 Million | -34.08 Million | -5.54 Million | -1.33 Million |
| Net Income | -198.13 Million | -121.82 Million | -165.36 Million | -3.41 Million | -2.52 Million |
| Depreciation & Amortization | 4.65 Million | 2.22 Million | 568 Thousand | 43 Thousand | - |
| Deferred income taxes | -279 Thousand | -964 Thousand | -624 Thousand | 1.86 Million | - |
| Stock-based compensation | 13.91 Million | 6.45 Million | 1.74 Million | 391 Thousand | - |
| Change in working capital | 2.64 Million | -35.4 Million | 31.17 Million | 164 Thousand | 492 Thousand |
| Other non-cash items | 11.79 Million | 17.67 Million | 98.41 Million | -4.59 Million | 703 Thousand |
| Investing Cash Flow | 18.71 Million | -47.09 Million | -73.62 Million | -1.06 Million | - |
| Investments in PPE | -8.72 Million | -16.09 Million | -4.15 Million | -639 Thousand | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -104.95 Million | -123.33 Million | -81.98 Million | - | - |
| Sales/Maturities of investments | 132.55 Million | 93 Million | 13 Million | - | - |
| Other Investing Activities | -170 Thousand | -665 Thousand | -496 Thousand | -423 Thousand | - |
| Financing Cash Flow | 655 Thousand | 181.49 Million | 269.27 Million | 34.93 Million | 9.98 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 655 Thousand | 185.31 Million | 270.36 Million | 34.95 Million | 9.98 Million |
| Other Financing Activities | 655 Thousand | -3.82 Million | -1.08 Million | -20 Thousand | 29.94 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 9.14 Million | 2.45 Million | 1.18 Million | 250 Thousand | - |
| Inventory | - | - | - | - | - |
| Other working capital | -9.14 Million | -37.85 Million | 29.99 Million | -86 Thousand | 492 Thousand |
| Cash at beginning of period | 201.11 Million | 198.54 Million | 36.97 Million | 8.64 Million | - |
| Cash at end of period | 55.07 Million | 201.11 Million | 198.54 Million | 36.97 Million | 8.64 Million |
| Capital Expenditure | -8.72 Million | -16.09 Million | -4.15 Million | -639 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -146.04 Million | 2.57 Million | 161.57 Million | 28.32 Million | 8.64 Million |
| Free Cash Flow | -174.13 Million | -147.92 Million | -38.23 Million | -6.18 Million | -1.33 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.32 Million | -45.76 Million | -198.13 Million | -65.64 Million | -50.7 Million | -42.38 Million |
| Depreciation & Amortization | 1.53 Million | 1.31 Million | 4.65 Million | 1.24 Million | 1.23 Million | 1.11 Million |
| Deferred income taxes | -134 Thousand | 134 Thousand | -279 Thousand | -4.64 Million | -108 Thousand | 31 Thousand |
| Stock-based compensation | 8.09 Million | 5.2 Million | 13.91 Million | 4.42 Million | 4.21 Million | 3.58 Million |
| Change in working capital | -4.74 Million | -30.11 Million | 2.64 Million | 14.45 Million | 2.39 Million | -5.58 Million |
| Other non-cash items | 19.6 Million | 15.22 Million | 11.79 Million | 6.29 Million | 3.79 Million | 2.41 Million |
| Investing Cash Flow | 6.89 Million | -37.03 Million | 18.71 Million | 41.28 Million | -37.77 Million | 27.86 Million |
| Investments in PPE | -1.9 Million | -2.32 Million | -8.72 Million | -1.84 Million | -2.9 Million | -1.97 Million |
| Acquisitions | - | - | - | -43.12 Thousand | 34.86 Thousand | - |
| Investment purchases | -28.7 Million | -107.2 Million | -104.95 Million | -4.41 Million | -54.88 Million | 7000.00 |
| Sales/Maturities of investments | 37.5 Million | 72.5 Million | 132.55 Million | 47.53 Million | 20.02 Million | 30 Million |
| Other Investing Activities | 8.79 Million | -34.7 Million | -170 Thousand | 43.12 Thousand | -34.86 Thousand | -170 Thousand |
| Financing Cash Flow | 35 Thousand | 157.32 Million | 655 Thousand | 194 Thousand | 318 Thousand | 75 Thousand |
| Debt repayment | - | -6 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 151.32 Million | 36 Thousand | 655 Thousand | 194 Thousand | 318 Thousand | 75 Thousand |
| Other Financing Activities | -151.29 Million | 157.29 Million | 655 Thousand | 194.00 | 318.00 | 75.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.35 Million | -5.88 Million | 9.14 Million | 2.27 Million | 5.75 Million | 1.6 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.39 Million | -24.23 Million | -9.14 Million | 12.17 Million | -3.35 Million | -7.19 Million |
| Cash at beginning of period | 94.16 Million | 41.57 Million | 201.11 Million | 43.95 Million | 134.07 Million | 146.95 Million |
| Cash at end of period | 55.6 Million | 94.16 Million | 55.07 Million | 41.57 Million | 57.45 Million | 134.07 Million |
| Capital Expenditure | -1.9 Million | -2.32 Million | -8.72 Million | -1.84 Million | -2.9 Million | -1.97 Million |
| Effect of forex changes on cash | - | - | - | -13.56 Million | - | 13.56 Million |
| Net cash flow / Change in cash | -38.56 Million | 52.58 Million | -146.04 Million | -2.38 Million | -76.61 Million | -12.88 Million |
| Free Cash Flow | -47.39 Million | -70.03 Million | -174.13 Million | -45.7 Million | -42.07 Million | -42.79 Million |
1530
DNR
123700
TIL
SIHBY
OCUP